GlassScriptPhysician profile
Omar Hamoui
NPI 1992058333
$6,967.32
in general payments reported to CMS, 2019-2025
37 companies · $2,247 in 2025
The $2,247 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.62 · 2022: $493 · 2023: $1,403 · 2024: $2,757 · 2025: $2,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,407.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $664.82 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $551.64 | 2023-2025 | Opsumit, Uptravi |
| Boston Scientific Corporation | $490.22 | 2023-2025 | Watchman Access System, Watchman Flx, S-Icd System Magnet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $393.41 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $385.33 | 2023-2025 | |
| Amgen INC. | $380.72 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $360.40 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $329.81 | 2024-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $297.20 | 2023-2025 | Wainua, Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.83 | 2023-2025 | Jardiance |
| Scpharmaceuticals INC. | $290.08 | 2023-2025 | |
| Pfizer INC. | $279.78 | 2023-2025 | |
| Coloplast Corp | $265.09 | 2022 | |
| Merck Sharp & Dohme LLC | $228.63 | 2023-2025 | Verquvo, Capvaxive |
| Kestra Medical Technology Services, INC. | $217.16 | 2024-2025 | Assure Wcd |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $168.26 | 2023-2025 | Onpattro, Amvuttra |
| Cvrx, INC. | $163.47 | 2022-2024 | Barostim Neo System |
| Inari Medical, INC. | $141.70 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $136.84 | 2023 | Penumbra System |
| Abiomed | $124.43 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $93.73 | 2024-2025 | |
| Intuitive Surgical, INC. | $88.62 | 2022 | |
| Heartflow, INC. | $76.21 | 2025 | |
| Siemens Medical Solutions USA, INC. | $67.62 | 2021 | |
| Teleflex LLC | $61.39 | 2022-2025 | Vascband |
| Bridgebio Pharma, INC. | $58.50 | 2025 | Attruby |
| Chiesi USA, INC. | $48.73 | 2024-2025 | Kengreal, Cleviprex |
| Kiniksa Pharmaceuticals International, Plc | $41.22 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $41.13 | 2025 | Nexletol |
| Lilly USA, LLC | $39.53 | 2025 | Mounjaro, Zepbound |
| Tactile Systems Technology INC | $38.82 | 2024 | Entre Plus, Flexitouch Plus |
| Procept Biorobotics Corporation | $31.12 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $30.31 | 2024 | |
| Abbott Laboratories | $27.14 | 2024 | Cardiomems |
| Inspire Medical Systems, INC. | $25.82 | 2024 | Inspire |
| Vital Connect, INC | $22.35 | 2025 | Vitalpatch Rtm |
| Masimo Corporation | $13.26 | 2023 | Set and Rainbow Set |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hamoui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.